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Abstract
Background: A Body Shape Index (ABSI) had been derived from a study of the United States National Health and Nutrition
Examination Survey (NHANES) 1999–2004 mortality data to quantify the risk associated with abdominal obesity (as indicated
by a wide waist relative to height and body mass index). A national survey with longer follow-up, the British Health and
Lifestyle Survey (HALS), provides another opportunity to assess the predictive power for mortality of ABSI. HALS also
includes repeat observations, allowing estimation of the implications of changes in ABSI.
Methods and Findings: We evaluate ABSI z score relative to population normals as a predictor of all-cause mortality over 24
years of follow-up to HALS. We found that ABSI is a strong indicator of mortality hazard in this population, with death rates
increasing by a factor of 1.13 (95% confidence interval, 1.09–1.16) per standard deviation increase in ABSI and a hazard ratio
of 1.61 (1.40–1.86) for those with ABSI in the top 20% of the population compared to those with ABSI in the bottom 20%.
Using the NHANES normals to compute ABSI z scores gave similar results to using z scores derived specifically from the
HALS sample. ABSI outperformed as a predictor of mortality hazard other measures of abdominal obesity such as waist
circumference, waist to height ratio, and waist to hip ratio. Moreover, it was a consistent predictor of mortality hazard over
at least 20 years of follow-up. Change in ABSI between two HALS examinations 7 years apart also predicted mortality
hazard: individuals with a given initial ABSI who had rising ABSI were at greater risk than those with falling ABSI.
Conclusions: ABSI is a readily computed dynamic indicator of health whose correlation with lifestyle and with other risk
factors and health outcomes warrants further investigation.
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ABSI, change in ABSI affects mortality risk. (3) Follow-up was
relatively short (averaging 5 years), so that it was not shown that
ABSI continues to be a predictor of risk with longer follow-up.
The Health and Lifestyle Survey (HALS) provides an opportunity to examine these questions in a different large national
sample, in this case from Britain, thus extending our understanding of ABSI as a predictor of mortality hazard. We build on recent
work that found ABSI to be a robust predictor of mortality hazard
in HALS [7].
This paper has the following structure: (1) We briefly introduce
the HALS data and the analysis methods we adopt; (2) we analyze
mortality hazard as a function of ABSI in HALS, with comparison
to widely used anthropometric measures, including WHR; (3) we
evaluate mortality hazard as a function of change in ABSI between
the 2 HALS examinations spaced 7 years apart and the evolution
of ABSI-associated risk over the follow-up period.

Introduction
A Body Shape Index (ABSI) was developed as a way to quantify
the risk associated with abdominal obesity, as indicated by a wide
waist relative to height and body mass index (BMI) [1]. Above
average ABSI was associated with substantially higher risk of death
in the United States (USA) National Health and Nutrition
Examination Survey (NHANES) 1999–2004 sample, and the
excess mortality hazard associated with high ABSI was greater
than that associated with above-average body mass index (BMI) or
waist circumference (WC) [1]. Several studies have sought to
quantify associations between ABSI and adverse outcomes other
than death, including diabetes [2], metabolic syndrome [3], and
high blood pressure [4,5]. ABSI seems a promising metric of
health risk associated with abdominal adiposity [6].
However, several limitations of the NHANES sample were
identified [1]. (1) Hip circumference was not measured, so ABSI
could not be directly compared to waist-to-hip ratio (WHR), a
popular alternative measure of body shape. Waist to height ratio
(WHtR) was also not directly evaluated against ABSI as a
predictor of mortality. (2) Anthropometric measurements were
only taken on one occasion for each individual, so it is unknown to
what extent ABSI varies over time and whether, for given initial
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Methods
HALS Data
The first Health and Lifestyle Survey (HALS1) was carried out
between September 1984 and June 1985. HALS1 was designed to
sample adults (age 18 and over) living in private households in
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NHANES 1999–2004 and for HALS1 using smoothing spline fits
to the mean and standard deviation of ABSI by age and sex,
similar to [1]. We considered as predictors ABSI z scores
computed using the HALS normals (denoted ABSI (H)) as well
as those computed using the NHANES normals (denoted ABSI
(N)). The latter affords more direct comparison to the previous
analysis of NHANES [1]. All other anthropometric variables were
converted to z scores using normals obtained from the HALS1
population with the same procedure as for ABSI (H).
The hazard ratios obtained from our Cox proportional hazard
regressions quantify the mortality risk elevation per standard
deviation increase in each predictor variable, but cannot be readily
compared to determine which variable is the best predictor of
mortality. To quantitatively evaluate whether ABSI is a better
predictor of mortality hazard than related anthropometric metrics
such as WHtR and WHR, we compared the Akaike information
criterion (AIC) scores from each regression [16]. The AIC are
scaled to produce AIC difference scores Di For the best performing
model (with lowest AIC) Di ~0, while all other models have
positive Di [16]. The likelihood of each model given the data is
proportional to e{Di =2 [16]. Thus, we considered D i w6 to indicate
models that perform significantly worse than the best-performing
model (at the 95% confidence level) as mortality predictors for the
sampled population (loge ( 0:95
0:05 )&3~6=2). We also calculated
coefficients of determination R2, denoting the proportion of
variation in mortality explained by the predictors of each model,
relative to a reference model containing only age and sex as
predictors [17].
The NHANES 1999–2004 sample had available mortality
follow-up for only a median of 5 years [1]. To evaluate the ability
of ABSI to predict mortality hazard at longer lead times, we also
used Cox proportional hazard regression on 5-year slices of the 24year HALS follow-up. For each 5-year period, the regression was
performed on those who were alive at the beginning of the period,
and the outcome considered was limited to deaths that occurred
during the period.
To place this study in the context of our previous work with
NHANES, we compared population normals for ABSI and other
body measures (height, weight, WC, BMI) between the two
studies, and also compared mortality hazards as functions of ABSI
for the two samples. These comparisons were intended to be
informal, as we did not attempt here a meta-analysis that adjusts
for differences between the two samples in such attributes as
ethnicity and length of follow up.

Great Britain (England, Wales, and Scotland) [8]. Addresses were
randomly selected from electoral registers using a three-stage
design. One adult resident was randomly selected from each
chosen address. HALS1 included a comprehensive interview
covering health-related attitudes and behaviors; clinical measurements made by a nurse; and a self-completion questionnaire for
psychological testing. In total, 7414 individuals completed the
interview and the clinical measurements. The sample was broadly
representative of the British population in terms of region,
employment status, national origin, and age. Compared to the
national census there was a slight excess of women in their 20 s to
40 s and men older than 60, presumably because these age groups
were more likely to be found at home [8]. Clinical measurements
included height, weight, and girth (WC); these were not measured
for pregnant women or for those missing limbs. WC was measured
with a plastic tape midway between the lowest rib and the top of
the hip [9]. Hip circumference at the top of the iliac crest was also
measured for most of the sample.
The Health and Lifestyle Survey: Seven-Year Follow-Up
(HALS2) was carried out in September 1991 to October 1992.
HALS2 re-surveyed and measured, using similar protocols, all
HALS1 participants who could be traced [10]. Further, National
Health Service records have been used to identify deaths and
cancer cases in HALS participants through June 2009, representing over 24 years of follow-up from the beginning of HALS1.
We obtained public-use versions of the HALS data, including
anthropometric measurements and follow-up for mortality, from
the United Kingdom Data Service, which has processed the data
for quality control and to remove personally identifying information [11–13]. All protocols for HALS were approved by the British
Medical Association Ethical Committee. Participant informed
consent for the clinical measurements was recorded in writing
[8,10].
A total of 7011 individuals in our sample had height, weight,
and WC data from HALS1 together with follow-up for mortality
available (2203 deaths recorded).

Analysis Approaches
We used Cox proportional hazard regression with age as the
timescale [1,14] to correlate all-cause mortality from the HALS
sample with ABSI and with other variables, including BMI, WC,
WHR, and WHtR. For each regression, sex was also included as
an explanatory variable. Analyses were implemented in the
computer language R, using the survival package for proportional
hazard regression [15].
ABSI is defined as (Equation 3 in [1]):
ABSI~

WC
BMI2=3

:
height1=2

Results
Anthropometric Risk Factors for Mortality in HALS1

ð1Þ

The British HALS1 sample was, on average, considerably
thinner and narrower-waisted than the later USA NHANES
1999–2004 sample (Table 1). Their mean ABSI was lower than
seen in NHANES, meaning that waist circumferences in HALS
averaged lower than would have been expected for their weight
based on the NHANES sample. The mean ABSI (N) z score,
which adjusts for differences in the age and sex composition of the
two samples, was lower in HALS by 0.9 of the NHANES
population standard deviation (Table 1). The cumulative distribution functions of ABSI z scores (Figure 1) highlights the large
fraction of the HALS sample that had smaller ABSI (N) than
typically seen in NHANES (z scores v{1), as indicated by the
HALS curve being above NHANES for any given ABSI z score.
The very highest values of ABSI (z scores w2) are the exception
due to a small fraction of HALS having very high scores (Figure 1).
As in NHANES, there was little correlation between ABSI and

If SI units are used (m for height and WC, kg m{2 for BMI),
the units of ABSI are m11=6 kg{2=3 : The ABSI z score is defined as
(Equation 4 in [1]):
ABSI z score~

ABSI{ABSImean
,
ABSISD

ð2Þ

where ABSImean and ABSISD designate age- and sex-specific
population means and standard deviations. We have tabulated
ABSImean and ABSISD estimated from the NHANES 1999–2004
population [1]. For the present analysis of the HALS population,
we generated normals (ABSImean and ABSISD ) for both the
PLOS ONE | www.plosone.org
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Figure 1. Cumulative distribution function for ABSI z score (calculated using NHANES normals) in the NHANES 1999–2004
compared to the HALS1 samples, showing the mostly lower values of ABSI seen in HALS. For each sample, the 1st through the 99th
percentiles are plotted.
doi:10.1371/journal.pone.0088793.g001

BMI z scores (r~{0:075 using ABSI(H), or r~{0:071 using
ABSI(N)).
As found for NHANES 1999–2004 [1], ABSI z score was a
strong linear predictor of HALS log mortality hazard, indicating
that those with higher ABSI faced greater risk of premature death.
ABSI (N) and ABSI (H) were comparably good linear predictors,
as shown by the similarity of the Akaike information criterion
scores (Di in Table 2). WC and WHtR z scores were also

significant linear predictors of log mortality hazard in HALS, with
WHtR outperforming WC, but, as shown by the respective model
Di, both were significantly weaker predictors than ABSI (H) or (N)
(Table 2). BMI z score was not a significant linear predictor of
mortality hazard (Table 2). The R2 values for each model support
the ranking of predictor variables given by Di, with ABSI
explaining more of the population mortality variability than the
other anthropometric measures (Table 2). Given the similarly good
performance of ABSI (H) and ABSI (N), all analyses presented
below will use the ABSI z scores calculated using NHANES
normals (ABSI (N)), unless otherwise specified.
Estimating mortality hazard by quintile for ABSI and the other
anthropometric measures offers more insight into the relative risk
associated with different metrics (Table 3). Relative to the middle
quintile, the lower quintiles of ABSI z score had significantly
reduced mortality hazard, while the top quintile showed significantly elevated mortality hazard, with &60% difference in
mortality hazard seen between the two extreme quintiles. This
hazard elevation for increasing ABSI was similar in magnitude to
that seen in NHANES 1999–2004 [1]; the relative mortality
hazard for the top quintile compared to the bottom quintile of
ABSI z score was 1.61 (95% confidence interval, 1.40–1.86) for
HALS compared to 2.04 (1.43–2.92) for NHANES.
Plotting nonparametric smoothing spline regressions of mortality hazard against ABSI z score for both cohorts (Figure 2) again

Table 1. HALS and NHANES means of body measures.

HALS

NHANES

Height (cm)

166.4

167.7

Weight (kg)

68.1

78.7

BMI (kg m22)

24.5

27.9

WC (cm)

82.9

95.8

WHtR

0.499

0.572

ABSI (m11/6 kg22/3)

0.0763

0.0808

ABSI z score

20.90

20.01

Comparison of mean values in HALS1 and in NHANES 1999–2004 nonpregnant
adults. ABSI z scores are based on the NHANES 1999–2004 population normals.
doi:10.1371/journal.pone.0088793.t001
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Change in ABSI and Predictive Power Over Time

Table 2. Mortality hazard association with HALS1 body size
and shape.

Since anthropometric measurements for much of the sample are
available for both HALS1 and HALS2, we could consider how
ABSI changed over the intervening 7 years and how this impacted
the subsequent mortality risk. Between HALS1 and HALS2, BMI
and waist circumference on average increased by about 0.3
standard deviations even after controlling for aging by using z
scores (Table 5), a trend also seen over this time period in other
countries [19]. ABSI also increased, by about 0.2 standard
deviations, suggesting that waistlines were expanding, on average,
faster than the 2/3 power of weight used in the definition of ABSI.
By contrast, there was little change in mean waist to hip ratio
(Table 5). While ABSI increased on average, there was wide
variation between individuals, with the standard deviation of the
change between HALS1 and HALS2 approaching 1 (Table 5).
Along with the ABSI z scores at baseline (HALS1) and on 7year follow up (HALS2), the change in z score between HALS1
and HALS2 (DABSI) was a predictor of mortality hazard over the
period following HALS2. Increasing ABSI (positive DABSI)
correlated with greater risk compared to decreasing ABSI
(negative DABSI) (Table 6). Table 6 also presents several
regression models that serve to illustrate the relative mortality
associations. Model A shows that the baseline (HALS1) ABSI
value and the change over time (DABSI) each make similarly
significant contributions to mortality hazard. Model B demonstrates that given the later (HALS2) measurements, past change in
ABSI was no longer a significant predictor of risk. Finally, Model
C shows that, as would be expected, the more recent (HALS2)
ABSI data are better at predicting subsequent mortality than the
earlier HALS1 measurement.
In contrast to the findings with ABSI, changes in the z scores of
the other anthropometric measures considered (BMI, WC, WHtR,
WHR) were not significant linear predictors of mortality hazard
(results not shown).
Table 7 shows the mortality hazard ratio for the baseline HALS
ABSI z score computed for 5 year intervals after study initiation.
The mortality risk is significant and of a similar magnitude for
each lead-time interval, up to at least 20 years after the baseline
measurements (pv0:05 for each 5-year interval, except for 21–24
years, where p~0:051).

R2

Hazard ratio per SD increase

Di

ABSI (N)

1.13 (1.09–1.16)

0

0.008

ABSI (H)

1.18 (1.13–1.23)

0.2

0.008

BMI

1.00 (0.96–1.05)

55.6

0.000

WC

1.09 (1.03–1.14)

43.3

0.002

WHtR

1.11 (1.06–1.16)

34.6

0.003

Results of Cox proportional hazard modeling for mortality risk with ABSI, BMI,
WC, or WHtR z scores at HALS1 taken as linear predictors. Ranges in
parentheses are 95% confidence intervals.
SD = standard deviation; Di = Akaike information criterion score difference
relative to the best performing model shown (see Methods for details);
R2 = coefficient of determination; ABSI(N) and ABSI(H) refer to ABSI z scores
calculated using NHANES or HALS normals, respectively.
doi:10.1371/journal.pone.0088793.t002

shows that the relative risks found for HALS are similar in
magnitude to those seen in NHANES 1999–2004, although the
mortality hazard in HALS appears to increase less steeply at high
ABSI (z scores w0) than was seen in NHANES.
WC and WHtR also showed elevated risk at the highest quintile
in HALS, though unlike ABSI they did not show significantly
reduced risk in the below-average quintiles (Table 3). By contrast,
BMI showed the same U-shaped association with mortality hazard
seen in NHANES 1999–2004 and in other studies [18], with both
the lowest and highest quintiles of the HALS sample subject to
elevated risk compared to the middle quintile (Table 3).
Next, we compared ABSI to WHR as a predictor of mortality.
(We did not include WHR in comparisons just presented because
hip circumference was measured only for part of HALS1, reducing
the sample size from 7011 to 4454.) As Table 4 shows, elevated
ABSI and WHR were both associated with increased mortality
hazard, although the association with ABSI was significantly
stronger, as indicated by the model Di. The two indicators were
positively correlated (r~z0:530 for the z scores), inasmuch as
high ABSI and high WHR both indicate a thick-waisted body
shape. However, when ABSI and WHR were combined in the
same predictive model, ABSI retained its predictive ability while
WHR showed no significant association, suggesting that knowing
WHR offered no added predictive value given ABSI (Table 4).

Discussion and Conclusions
The relatively large, nationally representative HALS sample,
resurvey, and long-term follow-up has previously been used to

Table 3. Mortality by quintile.

Hazard ratio
Quintile

ABSI (N)

ABSI (H)

BMI

WC

WHtR

1 (lowest)

0.77 (0.66–0.88)

0.83 (0.72–0.95)

1.35 (1.17–1.55)

1.03 (0.90–1.18)

1.01 (0.89–1.16)

2

0.78 (0.68–0.89)

0.92 (0.80–1.05)

1.14 (0.99–1.31)

0.97 (0.85–1.11)

1.00 (0.86–1.14)

3 (reference)

1

1

1

1

1

4

0.97 (0.85–1.11)

1.07 (0.94–1.22)

1.06 (0.93–1.21)

1.03 (0.90–1.17)

1.14 (1.00–1.30)

5 (highest)

1.23 (1.09–1.40)

1.35 (1.18–1.53)

1.23 (1.08–1.39)

1.22 (1.07–1.39)

1.34 (1.18–1.53)

Cox proportional hazard modeling for mortality risk with ABSI, BMI, WC, or WHtR z score quintiles at HALS1 taken as the predictors. Hazard ratios are relative to the
middle quintile in each case. Ranges in parentheses are 95% confidence intervals.
ABSI(N) and ABSI(H) refer to ABSI z scores calculated using NHANES or HALS normals, respectively.
The between-quintile cut points are {2:02,{1:32,{0:67,z0:177 for ABSI (N); {0:76,{0:288,z0:128,z0:681 for ABSI (H); {0:836,{0:375,z0:0805,z0:71 for BMI;
{0:804,{0:331,z0:121,z0:746 for WC; and {0:807,{0:339,z0:112,z0:727 for WHtR.
doi:10.1371/journal.pone.0088793.t003
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Figure 2. Mortality hazard by ABSI for NHANES 1999–2004 compared to HALS1. Estimates are from proportional hazard modeling where
log mortality hazard is a smoothing-spline function in ABSI z score (calculated using NHANES normals). Curves are positioned so that an ABSI z score
of 0 has a relative death rate of 1. Dashed curves show 95% confidence intervals. The ranges shown cover the 1st through 99th percentiles of ABSI in
each sample. The vertical axis is logarithmic.
doi:10.1371/journal.pone.0088793.g002

these findings by showing that the recently developed ABSI is a
robust predictor of mortality hazard in HALS, compared to the
previously evaluated anthropometric indices.
We found that while waist to hip ratio was associated with
mortality, WHR did not improve predictions when
included as a covariate with ABSI. Since determining
ABSI only requires a waist circumference measurement
in addition to the standard height and weight measurements
used to determine BMI while WHR additionally requires
a hip circumference measurement, ABSI may also be the
more clinically convenient of the two metrics. (By this criterion,
WHR could be preferred in situations where height and weight
measurements are not routinely obtained.) Waist circumference
alone, or waist to height ratio, are metrics that require no

study health behaviors and their association with mortality and
cancer hazards. For example, WHtR and WHR were both
significant predictors of mortality hazard in the HALS sample,
whereas BMI was not [20]. The superiority of WHtR as a
mortality predictor in the HALS sample was confirmed by a later
study using mortality follow-up to 2006 [21]. An index of poor
health behaviors including smoking, inactivity, eating few fruits
and vegetables, and overindulgence in alcohol was a strong
predictor of mortality hazard in HALS [22]. Here, we extend

Table 4. HALS1 mortality hazard association with ABSI versus
waist to hip ratio.

Hazard ratio per SD increase

Di

R2

ABSI

1.14 (1.09–1.19)

0

0.007

WHR

1.10 (1.04–1.16)

23.3

0.002

2.0

0.007

Combined:
ABSI

1.14 (1.08–1.20)

WHR

1.00 (0.93–1.06)

Table 5. Anthropometry changes between HALS1 and
HALS2.

Results of Cox proportional hazard modeling for mortality risk with ABSI or WHR
z scores, or both, taken as linear predictors. Ranges in parentheses are 95%
confidence intervals. Only the subsample with hip measurements in HALS1 is
used (n~4454; 1408 deaths).
SD = standard deviation; Di = Akaike information criterion score difference
relative to the best performing model shown (see Methods); R2 = coefficient of
determination.
doi:10.1371/journal.pone.0088793.t004

PLOS ONE | www.plosone.org

Mean

SD

ABSI

+0.16

0.98

BMI

+0.27

0.60

WC

+0.26

0.73

WHtR

+0.22

0.72

WHR

20.02

1.11

Mean and standard deviation (SD) of changes in z scores between HALS1 and
HALS2. All z scores are based on HALS1 population normals.
doi:10.1371/journal.pone.0088793.t005
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One uncertainty in our analysis is that the protocol for
measuring WC in HALS was not identical to that in NHANES,
which would bias the ABSI z scores for HALS computed using the
NHANES normals and which may conceivably have contributed
to the difference in ABSI distributions between the two
populations (Figure 1). Further quantification of the magnitude
of WC measurement differences between methods would clearly
be helpful. Nevertheless, the relatively good performance of the
NHANES population normals for constructing ABSI z scores for
HALS that are near-linear predictors of log mortality hazard
(Table 2 and Figure 2) provides some reason to believe that a
range of WC measurement protocols may yield broadly comparable values of ABSI. This is consistent with a meta-analysis that
found that WC measurement protocol did not influence the
associations observed between WC, mortality, cardiovascular
disease, and diabetes [24].
For given initial ABSI, we found that change in ABSI over time
was a predictor of all-cause mortality hazard, with increasing ABSI
associated with increased risk. By contrast, studies have typically
not found simple associations between change in BMI and
mortality. Intentional weight loss may have better outcomes than
unintended weight loss [25–29], while a large observational study
found that decreasing cardiorespiratory fitness, but not BMI
change, increases mortality hazard [30]. Complicating matters
further, the recent large randomized controlled trial of type 2
diabetics Look AHEAD found no impact on cardiovascular event
or mortality risk from a one-year intensive lifestyle intervention
which led to weight loss [31]. We further note that although the
current study only examines all-cause mortality as an outcome, the
HALS follow-up includes data on cause of death as well as on
cancer diagnosis, which could be used to study the health impacts
of body shape in more detail.
There is evidence from previous intervention studies that dieting
and exercise regimens can under some circumstances decrease
waist circumference by proportionally more than weight and thus
reduce ABSI [32–35]. Thus, it is worth exploring whether the
mortality reductions seen in some studies [36,37] among those
intending to lose weight, regardless of actual weight change, could
be correlated with reduction in ABSI related to lifestyle change.
Change in ABSI could potentially offer a novel, clinically
informative indicator of the effectiveness of lifestyle modification.
More analysis of population surveys such as HALS could lead to
better understanding of lifestyle and other correlates of ABSI
change. Data from randomized trials of weight loss such as Look
AHEAD could also be used to test whether change in ABSI is
predictive of impacts on other risk factors such as metabolic
syndrome components and on morbidity and mortality outcomes.

Table 6. Mortality hazard association with ABSI from HALS1
and HALS2.

Hazard ratio per SD increase
ABSI1

1.09 (1.04–1.14)

ABSI2

1.17 (1.12–1.23)

DABSI

1.05 (1.01–1.10)

Combined A:
ABSI1

1.19 (1.13–1.26)

DABSI

1.16 (1.10–1.22)

Combined B:
DABSI

0.97 (0.92–1.02)

ABSI2

1.19 (1.13–1.26)

Combined C:
ABSI1

1.03 (0.98–1.08)

ABSI2

1.16 (1.10–1.22)

Results of Cox proportional hazard modeling for mortality risk with ABSI1 or
ABSI2 (ABSI from HALS1 or HALS2 measurements, respectively) or DABSI (ABSI2
minus ABSI1), or combinations thereof, taken as linear predictors. Ranges in
parentheses are 95% confidence intervals. Only the subsample with
measurements in both HALS1 and HALS2 is used (n~4289; 1094 deaths).
SD = standard deviation.
doi:10.1371/journal.pone.0088793.t006

additional measurements compared to ABSI, but their association
with mortality was weaker than that of ABSI. To the extent that
these conclusions are borne out by similar analyses carried out on
more large samples, this suggests that ABSI is a superior basic
anthropometric indicator at least for the risk of premature death.
Despite the dynamic element in ABSI, we found that it was
sufficiently persistent to predict mortality hazard for at least 20
years after measurement (Table 7).
We used here ABSI z scores, instead of the raw values, as
predictors of risk. The reason for this is that ABSI tends to increase
strongly with age and to be substantially higher for men than for
women [1]. Using unadjusted ABSI as a predictor, as in several
recent studies [2–4,23], risks confounding body shape variation
with age and sex as risk factors in diverse population samples.
Calculation of z scores does add to the complexity of using ABSI in
the clinical setting, and whether simpler methods might provide
comparable performance is an important topic for future study.
Meanwhile, an online calculator of ABSI and its z score (using
NHANES normals) is available from us at http://www-ce.ccny.
cuny.edu/nir/sw/absi-calculator.html.

Table 7. Mortality hazard association with HALS1 ABSI z score.

Lead time (y)

n at beginning of period

Deaths during period

Hazard ratio per SD increase

0–5

7011

397

1.16 (1.08–1.24)

6–10

6614

470

1.15 (1.07–1.22)

11–15

6144

457

1.09 (1.02–1.17)

16–20

5687

497

1.12 (1.04–1.20)

21–24

5190

382

1.08 (1.00–1.17)

Results of Cox proportional hazard modeling for mortality risk at different lead times with ABSI (N) at HALS1 taken as a linear predictor. Ranges in parentheses are 95%
confidence intervals.
SD = standard deviation.
doi:10.1371/journal.pone.0088793.t007

PLOS ONE | www.plosone.org

6

February 2014 | Volume 9 | Issue 2 | e88793

Body Shape Dynamics

In summary, ABSI, previously found to be a strong risk factor
for mortality in a USA population sample (NHANES 1999–2004),
has similar associations with mortality hazard in a British sample
(HALS). Further, ABSI appears to outperform other popular
anthropometry-based measures of adiposity, such as WHtR and
WHR. Mortality risk appears to track changes in ABSI over time,
motivating further research into whether lifestyle or other
interventions could trigger reduction in ABSI and incur the
longevity benefits seen in this study for those with lower ABSI.
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